SLB1122168, an inhibitor targeting the sphingosine-1-phosphate (S1P) transporter Spns2 (with an IC50 of 94 nM for the mouse transporter), selectively reduces circulating lymphocyte counts without altering plasma S1P concentrations in mice at a dosage of 10 mg/kg.